Edition:
United States

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

23.60CAD
21 Feb 2018
Change (% chg)

-- (--)
Prev Close
$23.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,141,100
52-wk High
$30.56
52-wk Low
$11.20

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 8 2,012.47 2,215.00 1,868.50 2,092.20
Quarter Ending Jun-18 8 2,114.92 2,240.00 1,999.70 2,116.80
Year Ending Dec-18 19 8,423.88 9,160.00 7,956.00 9,211.78
Earnings (per share)
Quarter Ending Mar-18 7 0.68 0.90 0.46 1.00
Quarter Ending Jun-18 7 0.84 0.90 0.73 1.04
Year Ending Dec-18 17 3.49 4.57 2.96 5.52
LT Growth Rate (%) 2 -7.75 -2.00 -13.50 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 4.77 32.23 35.64
P/E High - Last 5 Yrs. 55.49 41.43 46.80
P/E Low - Last 5 Yrs. 55.49 23.37 24.18
Beta -0.42 0.81 0.81
Price to Sales (TTM) 0.72 6.23 8.67
Price to Book (MRQ) 1.22 4.34 5.21
Price to Tangible Book (MRQ) -- 4.82 6.35
Price to Cash Flow (TTM) 1.72 23.04 26.03
% Owned Institutions 66.84 1.25 2.27

Dividends

  Company industry sector
Dividend Yield -- 1.59 1.51
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.24 5.24
Payout Ratio(TTM) 0.00 45.32 44.74

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -10.51 8.65 9.21
Sales (TTM) vs TTM 1 Yr. Ago -10.43 6.38 7.55
Sales - 5 Yr. Growth Rate 31.85 9.89 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 205.93 14.70 16.86
EPS (TTM) vs TTM 1 Yr. Ago 160.21 -- --
EPS - 5 Yr. Growth Rate -- 10.39 11.51
Capital Spending - 5 Yr. Growth Rate -5.49 14.63 14.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.03 2.39 2.42
Current Ratio (MRQ) 1.26 3.34 3.38
LT Debt to Equity (MRQ) 492.13 9.17 12.01
Total Debt to Equity (MRQ) 522.34 12.36 15.38
Interest Coverage (TTM) 0.48 45.25 39.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 71.37 55.23 54.84
Gross Margin - 5 Yr. Avg. 72.57 52.57 52.61
EBITD Margin (TTM) 39.13 -- --
EBITD - 5 Yr. Avg 46.61 18.47 9.77
Operating Margin (TTM) 5.68 11.50 2.53
Operating Margin - 5 Yr. Avg. 6.38 14.27 5.00
Pre-Tax Margin (TTM) -14.47 11.87 3.34
Pre-Tax Margin - 5 Yr. Avg. -8.64 14.55 5.26
Net Profit Margin (TTM) 15.40 8.24 -0.18
Net Profit Margin - 5 Yr. Avg. -7.44 10.88 1.54
Effective Tax Rate (TTM) -- 22.44 22.12
Effective Tax Rate - 5 Yr. Avg. -- 23.60 24.22

Efficiency

  Company industry sector
Revenue/Employee (TTM) 416,912 922,196,718 822,216,427
Net Income/Employee (TTM) 64,186 107,909,384 96,151,835
Receivable Turnover (TTM) 3.63 5.30 5.40
Inventory Turnover (TTM) 2.16 2.60 3.51
Asset Turnover (TTM) 0.21 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 3.22 11.13 10.70
Return on Assets - 5 Yr. Avg. -1.87 12.64 12.00
Return on Investment (TTM) 3.59 14.02 13.57
Return on Investment - 5 Yr. Avg. -2.08 16.55 15.72
Return on Equity (TTM) 28.99 15.49 15.19
Return on Equity - 5 Yr. Avg. -11.89 17.63 16.94
  1 Year 3 Year 5 Year
Sales % -7.39 18.80 31.85
EPS (TTM) % -714.91 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Valeant Pharmaceuticals International Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -16.68 -12.91 63 53
13 Week 16.20 11.18 99 40
26 Week 29.48 16.91 99 20
52 Week 15.84 0.27 99 28
YTD -10.59 -11.99 99 39
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.